Lung Cancer: Advances in Basic and Clinical Research
Heine H. Hansen
Springer US, Dec 31, 1994 - Medical - 404 pages
Primary lung tumors are now a global health problem. The incidence has risen dramatically during the last 5--6 decades, reflecting the popularity of cigarette smoking.
In this, the fifth volume dealing with lung cancer in the series KappaCANCER TREATMENT AND RESEARCHkappa, many current research topics are covered by notable authorities, including chemoprevention, growth factors, multidrug resistance, new agents, and haematopoietic growth factors.
Altogether, the 17 chapters from twelve countries highlight some of the rapid developments taking place in basic and clinical research of lung cancer. These chapters not only give up-to-date information, they will also stimulate further research into this man-made disease which was almost unheard of a century ago.
47 pages matching etoposide in this book
Results 1-3 of 47
What people are saying - Write a review
We haven't found any reviews in the usual places.
Lung cancer chemoprevention
Smoking cessation programs
implications for early detection
12 other sections not shown
Other editions - View all
aclarubicin activity adenocarcinoma agents antibodies assay assessment biological bombesin bronchial cancer cell lines Cancer Res carcinogenesis carcinogens cell lines cell lung cancer chemoprevention chemotherapy cisplatin Clin Oncol clinical trials combination daunorubicin detection developed disease dose doxorubicin edatrexate effects epithelial etoposide evaluation expression Gazdar gene genetic GM-CSF growth factors Hansen histological human lung cancer IFNa IFNy increased inhibit interferon lesions lung cancer cell lung cancer patients lung carcinoma lung tumors lymph nodes malignant markers MDR1 mediastinal mediastinoscopy metastases multidrug resistance mutations Natl Cancer Inst neuroendocrine nicotine non-small cell lung NSCLC oncogene overexpression paclitaxel peptides Phase II trials primary tumors protein psychosocial pulmonary blastoma radiotherapy receptors recombinant response rate retinoids risk SCLC SCLC cell lines sensitivity small cell lung smoking cessation specific squamous cell carcinoma stage survival therapy Thorac tissue tobacco topoisomerase toxicity treatment tumor cells verapamil vitamin vitro xenografts